Bristol Myer to pay China’s drugmaker Sichuan $8.4b to develop cancer drug
HQ Team December 12, 2023: Bristol Myers Squib will pay a total of $8.4 billion to SystImmune Inc., the US arm of Chinese.
Drugs
Health
Pharma
Drugs
Health
Medical
Researchers uncover the role of dynein in breast cancer metastasis
HQ Team October 30, 2023: Researchers have unraveled a critical mechanism involving the dynein protein, shedding light on how it aids the spread.
Drugs
Health
Medical
Walkable environs cut risk of obesity-related cancers in women
HQ Team October 5, 2023: A new study by Columbia University Mailman School of Public Health and NYU Grossman School of Medicine says.
Drugs
Health
Pharma
Roche’s under-the-skin cancer injection gets Britain’s nod
HQ Team August 30, 2023: Roche’s atezolizumab drug Tecentriq, to treat cancer, was approved by Britain’s Medicines and Healthcare Products Regulatory Agency. Tecentriq.
Drugs
Health
Pharma
Merck & Co meets breast cancer therapy goal in last-stage trials
HQ Team July 29, 2023: Merck & Co., Inc., announced it has met one of the primary goals during a late-stage trial of.
Drugs
Health
Pharma
USFDA allows first oral contraceptive without a prescription
HQ Team July 14, 2023: The FDA has approved the first daily oral contraceptive pill, Opill, without prescription to be sold in the.
Drugs
Health
Medical
Estrogen fuels breast cancer development, finds study
Researchers say the hormone estrogen causes a molecular dysfunction by altering a cell’s DNA and causing the breast tissue to develop.
Drugs
Health
Pharma
India caps trade margins on 42 anti-cancer medicines
India has put a cap on the trade margin of 42 selected non-scheduled anti-cancer medicines, including ribociclib, which is used to treat breast.
Drugs
Pharma
Novartis AG stops breast cancer trial as it achieves early success
Novartis AG, the world's fourth-largest pharmaceutical company by revenue, announced its Kisqali drug reduced breast cancer recurrence when diagnosed at an early stage.